Evaluation of Implementation of Newborn Screening for Sickle Cell Disease Program in Selected Hospitals in Dar es Salaam, Tanzania
International Journal of Neonatal Screening · 15.04.2026 · 12 (2) · 24
DOI: 10.3390/ijns12020024 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 15.04.2026. Verfasst von Tunganege Matipa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Development Studies, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O…. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart, Lung and Blood Institute (NHLBI) of the US National Institutes of Health (NIH).
Abstract (Originalsprache)
Sickle cell disease (SCD) is a major public health concern in Tanzania where approximately 11,000 children are born with the condition annually. Newborn screening (NBS) enables early diagnosis and timely intervention. Despite the proven effectiveness of NBS in reducing early mortality from SCD, implementation in Tanzania remains limited to pilot programs at facilities such as Temeke and Amana Regional Referral Hospitals (RRHs) in the city of Dar-es-salaam. This study evaluated the implementation of NBS for the SCD Program at Temeke and Amana RRHs. An explanatory mixed-methods process evaluation was conducted between January 2022 and December 2024. Quantitative data were extracted from hospital registries and REDCap, while qualitative data were obtained from key informant interviews with 17 healthcare workers. Quantitative data were analyzed using SPSS v29.0, while qualitative transcripts were thematically analyzed using NVivo software version 15 to explore operational factors influencing implementation. A total of 10,711 newborns were screened across the two hospitals. Seventy-four (0.70%) newborns had homozygous SCD (HbS/S), whereas 1325 (12.53%) had sickle cell trait (HbA/S). Enrolment of infants diagnosed with SCD into comprehensive care declined substantially over time, from 65.6% in 2022 to 10.5% in 2024 at Temeke RRH, while Amana RRH recorded no enrolments beyond the first year of implementation. Qualitative findings highlighted facilitators for NBS such as maternal awareness, interdepartmental collaboration, and the availability of trained staff. However, implementation was hindered by inadequate refresher training, delayed staff incentives, supply shortages, and parental hesitancy influenced by cultural beliefs. This evaluation found a substantial decline in enrolment of newborns diagnosed with SCD into comprehensive care, driven by key operational challenges. Although early implementation benefited from trained, committed staff and interdepartmental collaboration, sustainability was limited by inadequate refresher training, delayed incentives, supply shortages, and parental hesitancy. Addressing these gaps through regular capacity building, strengthened supply chains, timely incentives, and culturally sensitive community education is critical to improving enrolment, continuity of care, and informing national scale-up of NBS for SCD in Tanzania.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Development Studies, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001, Tanzania.
- Sickle Pan African Research Consortium (SPARCO) Tanzania, Department of Haematology and Blood Transfusion, School of Diagnostic Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001,…
- Department of Haematology and Blood Transfusion, School of Diagnostic Medicine, College of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001, Tanzania.
- Department of Paediatrics and Child Health, School of Clinical Medicine, College of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001, Tanzania.
- Sickle Cell Disease Unit, Non-Communicable Diseases Section, Directorate of Curative Service, Ministry of Health, Dodoma P.O. Box 743, Tanzania.
- Department of Physiology, School of Biomedical Sciences, College of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001, Tanzania.
ORCID-Profile: Elia Nyangi, Agnes Jonathan, Emmanuel Balandya
Förderung
- National Heart, Lung and Blood Institute (NHLBI) of the US National Institutes of Health (NIH)
Zitieren
APA
Matipa, T., Nyangi, E., Jonathan, A., Ally, M., Chirande, L., Mpoto, A., Balandya, E., & Mahiti, G. R. (2026). Evaluation of Implementation of Newborn Screening for Sickle Cell Disease Program in Selected Hospitals in Dar es Salaam, Tanzania. International Journal of Neonatal Screening, 12(2), 24. https://doi.org/10.3390/ijns12020024
Vancouver
Matipa T, Nyangi E, Jonathan A, Ally M, Chirande L, Mpoto A, et al. Evaluation of Implementation of Newborn Screening for Sickle Cell Disease Program in Selected Hospitals in Dar es Salaam, Tanzania. International Journal of Neonatal Screening. 2026;12(2):24. doi:10.3390/ijns12020024
BibTeX
@article{Matipa2026,
author = {Matipa, Tunganege and Nyangi, Elia and Jonathan, Agnes and Ally, Mwashungi and Chirande, Lulu and Mpoto, Asteria and Balandya, Emmanuel and Mahiti, Gladys Reuben},
title = {Evaluation of Implementation of Newborn Screening for Sickle Cell Disease Program in Selected Hospitals in Dar es Salaam, Tanzania},
journal = {International Journal of Neonatal Screening},
year = {2026},
volume = {12},
number = {2},
pages = {24},
doi = {10.3390/ijns12020024}
}
EUVIMED